Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04491942 |
Title | Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | National Cancer Institute (NCI) |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA | CAN |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
University of California Davis Comprehensive Cancer Center | Sacramento | California | 95817 | United States | Details | |
National Cancer Institute Developmental Therapeutics Clinic | Bethesda | Maryland | 20892 | United States | Details | |
National Institutes of Health Clinical Center | Bethesda | Maryland | 20892 | United States | Details | |
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center | New York | New York | 10032 | United States | Details | |
Ohio State University Comprehensive Cancer Center | Columbus | Ohio | 43210 | United States | Details | |
University of Pittsburgh Cancer Institute (UPCI) | Pittsburgh | Pennsylvania | 15232 | United States | Details | |
University of Wisconsin Carbone Cancer Center - University Hospital | Madison | Wisconsin | 53792 | United States | Details | |
University Health Network-Princess Margaret Hospital | Toronto | Ontario | M5G 2M9 | Canada | Details |